Delivery Order SPE2DB20D2104-SPE2DB23FU55V
- Not listed
- This federal contract award is for the delivery of PEDVAXHIB vaccine vials (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency. The fixed-price delivery order, valued at $1,413.47, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 18, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
- This federal contract award from the Defense Logistics Agency (DLA) is a $2,379.46 firm fixed-price delivery order for the PEDVAXHIB vaccine vial (0.5 ml) placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $1,455.07, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 5, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a for-profit organization. Cencora, Inc....
- This federal contract award is for the PEDVAXHIB vaccine vial 0.5ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,362.66 and a performance period through May 21, 2025. The contract is not set aside for any special business type. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,226.41 and is a Firm Fixed Price Delivery Order that runs through October 30, 2023. The contract was awarded on October 27, 2023...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,085.49 firm fixed-price delivery order is for the supply of PEDVAXHIB vaccine vials (0.5 mL). The contract has an ultimate completion date of June 24, 2025 and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award, worth $5,687.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB vaccine vials (0.5ML) and has a completion date of February 6, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 26, 2024 with a completion date of December 27, 2024. The contract has a firm fixed price of $2,326.83. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is a delivery order worth $1,897.18 for the supply of PEDVAXHIB Vaccine vials, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on March 16, 2023, with a completion date of March 17, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of PEDVAXHIB vaccine vials (0.5 mL) to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,817.10, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price type and has an ultimate completion date of November 15, 2024. There is no set-aside designation for this award. Amerisourcebergen...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU55VDelivery Order
This federal contract award is for the delivery of the PEDVAXHIB vaccine vial 0.5ML to the Defense Logistics Agency (DLA). The $1,718.45 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of July 27, 2023. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order is likely part of the broader IDC, enabling the DLA to efficiently procure essential vaccine products for military and veteran healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/26/23 |